Can flies help humans treat neurodegenerative diseases?

被引:52
作者
Marsh, JL
Thompson, LM
机构
[1] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Dept Psychiat & Human Behav & Biol Chem, Irvine, CA 92697 USA
关键词
D O I
10.1002/bies.20029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases are becoming increasingly common as life expectancy increases. Recent years have seen tremendous progress in the identification of genes that cause these diseases. While mutations have been found and cellular processes defined that are altered in the disease state, the identification of treatments and cures has proven more elusive. The process of finding drugs and therapies to treat human diseases can be slow, expensive and frustrating. Can model organisms such as Drosophila speed the process of finding cures and treatments for human neurodegenerative diseases? We pose three questions, (1) can one mimic the essential features of human diseases in an organism like Drosophila, (2) can one cure a model organisms of human disease and (3) will these efforts accelerate the identification of useful therapies for testing in mice and ultimately humans? Here we focus on the use of Drosophila to identify potential treatments for neurodegenerative diseases such as Huntington's and we discuss how well these therapies translate into mammalian-systems. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:485 / 496
页数:12
相关论文
共 79 条
[1]  
[Anonymous], 2002, Huntington's disease
[2]   A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila [J].
Apostol, BL ;
Kazantsev, A ;
Raffioni, S ;
Illes, K ;
Pallos, J ;
Bodai, L ;
Slepko, N ;
Bear, JE ;
Gertler, FB ;
Hersch, S ;
Housman, DE ;
Marsh, JL ;
Thompson, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :5950-5955
[3]   Pharmacological prevention of Parkinson disease in Drosophila [J].
Auluck, PK ;
Bonini, NM .
NATURE MEDICINE, 2002, 8 (11) :1185-1186
[4]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[5]   Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin [J].
Boutell, JM ;
Thomas, P ;
Neal, JW ;
Weston, VJ ;
Duce, J ;
Harper, PS ;
Jones, AL .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1647-1655
[6]   THE GAL4 SYSTEM AS A TOOL FOR UNRAVELING THE MYSTERIES OF THE DROSOPHILA NERVOUS-SYSTEM [J].
BRAND, AH ;
DORMAND, EL .
CURRENT OPINION IN NEUROBIOLOGY, 1995, 5 (05) :572-578
[7]  
BRAND AH, 1993, DEVELOPMENT, V118, P401
[8]   Conformational disease [J].
Carrell, RW ;
Lomas, DA .
LANCET, 1997, 350 (9071) :134-138
[9]   Transcriptional dysregulation in Huntington's disease [J].
Cha, JHJ .
TRENDS IN NEUROSCIENCES, 2000, 23 (09) :387-392
[10]   Evidence for proteasome involvement in polyglutamine disease:: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro [J].
Chai, YH ;
Koppenhafer, SL ;
Shoesmith, SJ ;
Perez, MK ;
Paulson, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :673-682